Global Burden of Chronic Liver Disease and Temporal Trends: A Population‐Based Analysis From 1990 to 2021 With Projections to 2050
Liver International · 2025-06 · 45 (6)
DOI: 10.1111/liv.70155 ↗Kurz gefasst
Fachartikel in der Zeitschrift Liver International, online erschienen am 27.05.2025. Verfasst von Yunyu Zhao und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. Hauptthemen laut MEDLINE: Global Burden of Disease, Global Health, Liver Diseases. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Background and Aims Globally, the aetiology and epidemiology of chronic liver disease (CLD) are undergoing significant changes. We aimed to investigate the updated global burden of CLD, evaluate the cross‐country inequalities, and provide 2050 predictions.
Methods
Using the Global Burden of Disease Study (GBD) 2021 data resources, we analysed and forecasted CLD prevalence, incidence, and related death from 1990–2021 to 2050, respectively. We calculated average annual percent change (AAPC) by joinpoint regression model and quantified inequalities according to World Health Organisation‐recommended health equity standards.
Results
In 2021, the number of prevalent, incident CLD and related deaths globally were 1.7 billion (95% uncertainty interval (UI): 1.6–1.8), 58.4 million (95% UI: 54.2–62.8) and 1.4 million (95% UI: 1.3–1.5), respectively. During 1990–2021, the age‐standardised incidence rate (ASIR) increased, especially in those aged 15–49 (AAPC: 0.49%; 95% confidence interval [CI]: 0.45%–0.53%), in Europe (AAPC: 0.41%; 95% CI: 0.41%–0.42%) and the Americas (AAPC: 0.41%; 95% CI: 0.39%–0.42%), whereas the age‐standardised death rate (ASDR) decreased globally (AAPC: −1.26%; 95% CI: −1.35% [−1.17%]) and across subgroups. During 1990–2021, the ASIR of metabolic dysfunction‐associated steatotic liver disease (MASLD) increased the most in those aged 15–49 (AAPC: 0.72%; 95% CI: 0.67%–0.77%) and in the Western Pacific region (AAPC: 0.73%; 95% CI: 0.59%–0.86%). Socio‐demographic index (SDI)‐related inequalities decreased for the age‐standardised prevalence rate (ASPR) and ASIR of CLD but increased for ASDR, placing a disproportionately heavier burden on low‐SDI countries. From 2022 to 2050, the ASIR of CLD is projected to increase (AAPC: 0.20%; 95% CI: 0.19%–0.20%), but the ASDR is projected to decline (AAPC: −1.91%; 95% CI: −1.96% [−1.85%]).
Conclusions
This study's findings highlight targeted interventions for CLD disparities, focusing on MASLD management, the younger population (15–49 years), and socio‐demographic inequalities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hepatology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
- School of Mathematics and Statistics, Xi'an Jiaotong University, Xi'an, China.
- Division of Gastroenterology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
- Division of Gastroenterology and Hepatology, Department of Medicine, Stanford University Medical Center, Palo Alto, California, USA.
- Key Laboratory of Environment and Genes Related to Diseases (Xi'an Jiaotong University), Ministry of Education of China, Xi'an, Shaanxi, China.
- Key Laboratory of Surgical Critical Care and Life Support (Xi'an Jiaotong University), Ministry of Education of China, Xi'an, Shaanxi, China.
ORCID-Profile: Yi Liu, Fanpu Ji, Mindie H Nguyen
Förderung
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Zhao, Y., Bo, Y., Zu, J., Xing, Z., Yang, Z., Zhang, Y., Deng, Y., Liu, Y., Zhang, L., Yuan, X., Wang, Y., Henry, L., Ji, F., & Nguyen, M. H. (2025). Global Burden of Chronic Liver Disease and Temporal Trends: A Population‐Based Analysis From 1990 to 2021 With Projections to 2050. Liver International, 45(6). https://doi.org/10.1111/liv.70155
Vancouver
Zhao Y, Bo Y, Zu J, Xing Z, Yang Z, Zhang Y, et al. Global Burden of Chronic Liver Disease and Temporal Trends: A Population‐Based Analysis From 1990 to 2021 With Projections to 2050. Liver International. 2025;45(6). doi:10.1111/liv.70155
BibTeX
@article{Zhao2025,
author = {Zhao, Yunyu and Bo, Yajing and Zu, Jian and Xing, Zixuan and Yang, Zhanpeng and Zhang, Yue and Deng, Yujiao and Liu, Yi and Zhang, Lanting and Yuan, Xiao and Wang, Yuan and Henry, Linda and Ji, Fanpu and Nguyen, Mindie H},
title = {Global Burden of Chronic Liver Disease and Temporal Trends: A Population‐Based Analysis From 1990 to 2021 With Projections to 2050},
journal = {Liver International},
year = {2025},
volume = {45},
number = {6},
doi = {10.1111/liv.70155}
}
EUVIMED